Influenza Industry 2026

North American Influenza Industry 2026‑2030

North American influenza market projected at $5.1B by 2030. Landscape led by Sanofi, CSL Seqirus, GSK and AstraZeneca. Includes prevalence, mortality data and country forecasts 2026-2030.

US Influenza Industry 2026‑2030

US influenza market projected to surpass $4.5B by 2030 at 5.3% CAGR. Profiles Sanofi, CSL Seqirus, GSK, AstraZeneca and Moderna. Covers prevalence, death rates, vaccine segments and forecasts 2026-2030.

Global Influenza Industry 2026‑2030

Global influenza market forecast to exceed $12B by 2030 at 6.0% CAGR. Profiles Sanofi, CSL Seqirus, GSK, AstraZeneca and Roche. Covers prevalence, death rates, segments and forecasts 2026-2030.

European Influenza Industry 2026‑2030

European influenza market forecast to reach $3.4B by 2030 at 4.9% CAGR. Key players: GSK, Sanofi, CSL Seqirus and Viatris Europe. Covers prevalence, death rates, segments and forecasts 2026-2030.

Asian Influenza Industry 2026‑2030

Asian influenza market projected to exceed $2.8B by 2030 at 7.1% CAGR. Key players: Sanofi, CSL Seqirus, Sinovac, GC Biopharma and Hualan Bio. Includes prevalence data, death rates and country forecasts 2026-2030.

North European Influenza Industry 2026‑2030

• 300+ reports

• Influenza Death Rate, Influenza Prevalence…

• 100+ statistics

• Influenza Prevalence, Influenza Death Rate…

UK Influenza Industry 2026‑2030

UK influenza market forecast to surpass $580M by 2030 at 4.8% CAGR. Key players: GSK, Sanofi, CSL Seqirus and AstraZeneca UK. Covers prevalence, death rates, segments and forecasts 2026-2030.

East Asian Influenza Industry 2026‑2030

• 400+ reports

• Influenza Prevalence, Influenza Death Rate…

• 20+ statistics

• Influenza Prevalence, Influenza Death Rate…